Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06345599
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-03
First Post:
2024-02-01
Brief Title:
PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma PDAC NeoPRAG Study
Sponsor:
Second Affiliated Hospital of Soochow University
Organization:
Second Affiliated Hospital of Soochow University
Study Overview
Official Title:
Phase IPhase II Clinical Study of PRaG Therapy in Combination With Chemotherapy AG Regimen for Neoadjuvant Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma PDAC NeoPRAG Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to learn about Phase IPhase II Clinical Study of PRaG Therapy in Combination With Chemotherapy AG Regimen for Neoadjuvant Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma PDAC NeoPRAG StudyThe main question it aims to answer is to investigate the safety and efficacy of the PRaG treatment modality combined with chemotherapy neoadjuvant therapy for locally advanced pancreatic cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None